Frontiers in Immunology (Nov 2019)
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis
- Elin Engdahl,
- Elin Engdahl,
- Rasmus Gustafsson,
- Rasmus Gustafsson,
- Jesse Huang,
- Jesse Huang,
- Martin Biström,
- Izaura Lima Bomfim,
- Izaura Lima Bomfim,
- Pernilla Stridh,
- Pernilla Stridh,
- Mohsen Khademi,
- Mohsen Khademi,
- Nicole Brenner,
- Julia Butt,
- Angelika Michel,
- Daniel Jons,
- Maria Hortlund,
- Lucia Alonso-Magdalena,
- Anna Karin Hedström,
- Anna Karin Hedström,
- Anna Karin Hedström,
- Louis Flamand,
- Masaru Ihira,
- Tetsushi Yoshikawa,
- Oluf Andersen,
- Jan Hillert,
- Jan Hillert,
- Lars Alfredsson,
- Lars Alfredsson,
- Tim Waterboer,
- Peter Sundström,
- Tomas Olsson,
- Tomas Olsson,
- Ingrid Kockum,
- Ingrid Kockum,
- Anna Fogdell-Hahn,
- Anna Fogdell-Hahn
Affiliations
- Elin Engdahl
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Elin Engdahl
- Center for Molecular Medicine, Stockholm, Sweden
- Rasmus Gustafsson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Rasmus Gustafsson
- Center for Molecular Medicine, Stockholm, Sweden
- Jesse Huang
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Jesse Huang
- Center for Molecular Medicine, Stockholm, Sweden
- Martin Biström
- Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
- Izaura Lima Bomfim
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Izaura Lima Bomfim
- Center for Molecular Medicine, Stockholm, Sweden
- Pernilla Stridh
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Pernilla Stridh
- Center for Molecular Medicine, Stockholm, Sweden
- Mohsen Khademi
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Mohsen Khademi
- Center for Molecular Medicine, Stockholm, Sweden
- Nicole Brenner
- Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany
- Julia Butt
- Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany
- Angelika Michel
- Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany
- Daniel Jons
- Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Maria Hortlund
- Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
- Lucia Alonso-Magdalena
- Department of Neurology, Skåne University Hospital, Malmö, Sweden
- Anna Karin Hedström
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Anna Karin Hedström
- Center for Molecular Medicine, Stockholm, Sweden
- Anna Karin Hedström
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Louis Flamand
- Department of Microbiology, Infectious Disease and Immunology, Laval University, Quebec City, QC, Canada
- Masaru Ihira
- 0Clinical Engineering Technology, Fujita Health University School of Medical Sciences, Toyoake, Japan
- Tetsushi Yoshikawa
- 1Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan
- Oluf Andersen
- Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Jan Hillert
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Jan Hillert
- Center for Molecular Medicine, Stockholm, Sweden
- Lars Alfredsson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Lars Alfredsson
- 2Centre for Occupational and Environmental Medicine, Stockholm County Council, Stockholm, Sweden
- Tim Waterboer
- Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany
- Peter Sundström
- Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden
- Tomas Olsson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Tomas Olsson
- Center for Molecular Medicine, Stockholm, Sweden
- Ingrid Kockum
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Ingrid Kockum
- Center for Molecular Medicine, Stockholm, Sweden
- Anna Fogdell-Hahn
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Anna Fogdell-Hahn
- Center for Molecular Medicine, Stockholm, Sweden
- DOI
- https://doi.org/10.3389/fimmu.2019.02715
- Journal volume & issue
-
Vol. 10
Abstract
Human herpesvirus (HHV)-6A or HHV-6B involvement in multiple sclerosis (MS) etiology has remained controversial mainly due to the lack of serological methods that can distinguish the two viruses. A novel multiplex serological assay measuring IgG reactivity against the immediate-early protein 1 from HHV-6A (IE1A) and HHV-6B (IE1B) was used in a MS cohort (8,742 persons with MS and 7,215 matched controls), and a pre-MS cohort (478 individuals and 476 matched controls) to investigate this further. The IgG response against IE1A was positively associated with MS (OR = 1.55, p = 9 × 10−22), and increased risk of future MS (OR = 2.22, p = 2 × 10−5). An interaction was observed between IE1A and Epstein-Barr virus (EBV) antibody responses for MS risk (attributable proportion = 0.24, p = 6 × 10−6). In contrast, the IgG response against IE1B was negatively associated with MS (OR = 0.74, p = 6 × 10−11). The association did not differ between MS subtypes or vary with severity of disease. The genetic control of HHV-6A/B antibody responses were located to the Human Leukocyte Antigen (HLA) region and the strongest association for IE1A was the DRB1*13:01-DQA1*01:03-DQB1*06:03 haplotype while the main association for IE1B was DRB1*13:02-DQA1*01:02-DQB1*06:04. In conclusion a role for HHV-6A in MS etiology is supported by an increased serological response against HHV-6A IE1 protein, an interaction with EBV, and an association to HLA genes.
Keywords